Health Dictionary Find a Doctor

Oral cancer

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sargun Singh Walia M.B.B.S.[2], Michael Maddaleni, B.S., Simrat Sarai, M.D. [3]; Grammar Reviewer: Natalie Harpenau, B.S.[4]

Synonyms and keywords: Squamous cell carcinoma of mouth; Oral carcinoma; Carcinoma-in-situ of oral mucosa; Verrucous carcinoma of oral cavity

Overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sargun Singh Walia M.B.B.S.[2]; Grammar Reviewer: Natalie Harpenau, B.S.[3]

Overview

Oral cancer (or mouth cancer) is a type of head and neck cancer that involves any cancerous tissue growth located in the oral cavity. Oral cancer is a malignant growth that affects any part of the oral cavity, including the lips, gums, tongue, inside lining of the cheeks, roof of the mouth and floor of the mouth. It may arise as a primary lesion originating in any of the tissues in the mouth, by metastasis from a distant site of origin, or by extension from a neighboring anatomic structure, such as the nasal cavity. Alternatively, the oral cancers may originate in any of the tissues of the mouth, and may be of varied histologic types.

Classification

Oral cancer can be classified into three types based on the potential to spread to other parts of the body such as malignant tumors,precancerous conditions, and benign tumors. Most common type of malignant tumor of the mouth is squamous cell carcinoma. Squamous cell carcinoma is further classified by macroscopic and microscopic features. About 5% of oral cavity cancers are rare, malignant tumors that start in different types of cells in the oral cavity. These include: salivarygland cancer, melanoma, bone and soft tissue sarcomas, lymphomas and extramedullary plasmacytomas, hodgkin lymphoma, and non-Hodgkin lymphoma metastatic cancer.    

Pathophysiology

It is understood that oral cancer occurs as a the result of carcinogen-metabolizing enzymes, alcohol, tobacco and genetic factors. Cytotoxic enzymes, such as alcohol dehydrogenase, result in the production of free radicals and DNA hydroxylated bases. Alcohol dehydrogenase oxidizes ethanol to acetaldehyde, which is cytotoxic in nature. Cigarette smoke has various carcinogens that can lead to oral cancers. Low-reactive, free radicals in cigarette smoke interact with redox-active metals in saliva. The development of oral cancer is the result of multiple genetic mutations. These mutations occur in tumor suppressor genes (TSGs) and oncogenes. Squamous cell carcinoma is the most common malignancy of the oral cavity. It typically has three gross morphological growth patterns: exophytic, ulcerative, and infiltrative. Microscopically, oral cancers are broadly based and invasive through papillary fronds. Oral cancer constitutes of highly differentiated squamous cells lacking frank cytologic criteria of malignancy with rare mitoses.The surface of the lesion is covered with compressed invaginating folds of keratin layers. A stroma-like inflammatory reaction and a blunt pushing margin may be seen

Causes

Common causes of oral cancers include pre-malignant lesion, tobacco, alcohol, human papillomavirus, and hematopoietic stem cell transplantation. Seventy-five percent of oral cancer cases occur due to tobacco. It causes irritation of the mucous membrane in the mouth. HPV type 16 is the most common sub-type of human papilloma virus associated with oral cancer. 

Differentiating Oral cancer from other diseases

Oral cancer must be differentiated from actinic keratosis, dermatologic manifestations of oral leukoplakia, erythroplasia, lichen planus, and mucosal candidiasis.

Epidemiology and Demographics

The prevalence of oral cancer is estimated to be 91, 200 cases annually. The incidence of oral cancer is approximately 10.5 adults per 100,000 individuals worldwide, with a mortality rate of 1.2 per 100,000 individuals each year. Males are more commonly affected by squamous cell cancer of the oral cavity than females. The male to female ratio is approximately 6 to 1. Females are more commonly affected with adenocarcinoma of the hard palate. Oral cavity cancer more commonly affects individuals of the black population. Oral cavity cancer typically affects individuals of the lower-income patients.

Risk factors

The most potent risk factor in the development of oral cancer is alcohol intake and tobacco use. The other risk factors include male gender, age over 55 years, ultraviolet light, Fanconi anemia, dyskeratosis congenita, HPV infection, graft-versus-host disease (GVHD), mouthwash and irritation from dentures.

Screening

There is insufficient evidence to recommend routine screening for oral cancer.

Natural History, Complications and Prognosis

If left untreated, patients with oral cancer may progress to develop non-healing ulcer, which demonstrates growth over time. A neck mass may develop, possibly causing a mass defect. Depending on the extent of the tumor at the time of diagnosis, the prognosis varies. The 5-year survival rate for oral cancer diagnosed early is 75% compared to 20% for oral cancer diagnosed late. Complications of oral cancer include difficulty speaking, dysphagia , weight loss, bleeding and even death. 

Staging

According to the TNM staging system by the American Joint Committee on cancer, there are four stages of oral cancer based on the tumor size, lymph nodes involved, and metastasis.

History and Symptoms

A positive history of tobacco chewing or smoking, excessive alcohol intake, poor oral hygiene, metallic denture, betel quid use, diet rich in meats and HPV infection in sexual partner is suggestive of oral cancer. The most common symptoms of oral cancer include a sore, irritated lump or thick patch in the mouth, lip, or throat; a white or red patch in the mouth; persistent mouth pain; a lump in the neck; loose tooth; bleeding in the mouth; pain in one ear without hearing loss; weight loss, etc. 

Physical Examination

Common physical examination findings of oral cancer include a lump or thickening in the oral soft tissues, soreness, difficulty chewing or swallowing, ear pain, difficulty moving the jaw or tongue, hoarseness, numbness of the tongue or swelling of the jaw that causes dentures to fit poorly.

Laboratory Findings

Some patients with oral cancer may have elevated liver function tests, abnormal urea and electrolyte measurements, elevated calcium levels. Serum ferritin, alpha-anti-trypsin, and alpha-anti-glycoprotein levels may be increased in high-stage cancer of oral cavity; while those at any stage of the disease will have increased haptoglobin levels. Prealbumin levels are decreased slightly in persons at any stage.

X-ray

There are no x-ray findings associated with oral cancer. However, a chest x-ray may be helpful to diagnose metastases in the lungs, a site for second primary carcinoma and metastasis in hilar lymph nodes, ribs, or vertebrae. Jaw radiography may show invasion but may be inadequate to exclude bone invasion.

CT

Neck CT scans may be helpful in the diagnosis of oral cancer. CT scans can provide information about the size, shape and position of any tumor and may help identify enlarged lymph nodes

MRI

Neck MRI’s may be helpful in the diagnosis of oral cancer. MRI’s can provide detailed view of cancer spread. Magnetic resonance imaging offers an advantage over computed tomographic scans in the detection and localization of head and neck tumors and in the distinction of lymph nodes from blood vessels.

Other Imaging Findings

A PET scan may be diagnostic of spread of oral cancer. FDG-PET (18-fluorodeoxyglucose positron emission tomography) scanning is useful to identify the extent of cervical node metastasis.

Other Diagnostic Studies

Biopsy of the tumor tissue is diagnostic of oral cancer. Other diagnostic studies for oral cancer include endoscopy, indirect pharyngoscopy, laryngoscopy, exfoliative cytology, barium swallow, chest x-ray and bone scan.

Medical Therapy

The predominant therapy for oral cancer is surgical resection, radiation therapy, or a combination of both. Adjunctive chemotherapy, radiation, chemotherapy may be required. Radiation in the form of external-beam radiation therapy (EBRT) or interstitial implantation is used. Advantages of radiotherapy are that normal anatomy or function are maintained, and general anesthesia is not needed. Disadvantages of radiotherapy are that it is inefficient to treat large tumors, subsequent surgery is more difficult, oral mucositis, dry mouth (xerostomia), osteoradionecrosis (ORN) etc.

Surgery

Surgery is the mainstay of treatment for oral cancer. Surgical resection of full-extent of the oral cavity lesion should be done. Only surgical resection is done when oral cancer has been detected early but not yet metastasized. In advanced-stages and recurrent cancers, surgery is done in combination with radiation therapychemotherapy or targeted therapy. Depending on the stage of oral cancer, one or more of the various procedures listed are recommended: Tumor resection, mohs micrographic surgery, full or partial mandible resection, glossectomy, maxillectomy, Laryngectomy, Neck dissection, partial or selective neck dissection, modified radical neck dissection or radical neck dissection.

Primary Prevention

Effective measures for the primary prevention of oral cancer include tobacco cessation, alcohol cessation, HPV vaccine, and avoiding excessive sun exposure.

References

Template:WH Template:WS

Historical Perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sargun Singh Walia M.B.B.S.[2]; Grammar Reviewer: Natalie Harpenau, B.S.[3]

Overview

Hippocrates described the term “aphthae” in relation to the disorders of mouth in 370-460 B.C. By 1928, V. P. Blair of St. Louis was the first to advocate surgery as the best management for oral cancers. Cytotoxic chemotherapy was a major initiative in the 1970’s for the patients unfit for surgeries.

Oral cancer historical perspective

  • Between 370-460 B.C., in relation to disorders of the mouth the term “aphthae” was first used by Hippocrates.[1]
  • In 1838, the term melanoma was first proposed by Sir Robert Carswell, a British pathologist.[2]
  • In 1875, Bernard von Langenbeck respected the ramus of the mandible in continuity with the primary tumor.[3]
  • By 1928, V. P. Blair of St. Louis was the first to advocate surgery as the best management for oral cancers.
  • A major initiative of the 1970’s and 1980’s was cytotoxic chemotherapy for patients unfit for surgeries.
  • Verrucous carcinoma was first discovered in 1948 by Lauren V. Ackerman, an American physician.[4]

References

  1. Ship, Jonathan A. “Recurrent aphthous stomatitis: an update.” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 81.2 (1996): 141-147.
  2. Karamanou M, Liappas I, Stamboulis E, Lymperi M, Kyriakis K, Androutsos G (2012). “Sir Robert Carswell (1793-1857): coining the term “melanoma. J BUON. 17 (2): 400–2. PMID 22740229.
  3. Alberti PW (1975). “Panel discussion: the historical development of laryngectomy. II. The evolution of laryngology and laryngectomy in the mid-19th century”. Laryngoscope. 85 (2): 288–98. doi:10.1288/00005537-197502000-00006. PMID 1089857.
  4. Lauren Ackerman. Wikipedia. https://en.wikipedia.org/wiki/Lauren_Ackerman. Accessed on May 11, 2016

Template:WH Template:WS

Classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sargun Singh Walia M.B.B.S.[2], Simrat Sarai, M.D. [3]; Grammar Reviewer: Natalie Harpenau, B.S.[4]

Overview

Oral cancer can be classified into three types based on the potential to spread to other parts of the body such as malignant tumors,precancerous conditions, and benign tumors. Most common type of malignant tumor of the mouth is squamous cell carcinoma. Squamous cell carcinoma is further classified based on macroscopic and microscopic features. About 5% of oral cavity cancers are rare malignant tumors that start in different types of cells in the oral cavity. These include salivary gland cancer, melanoma, bone and soft tissue sarcomas, Lymphomas and extramedullary plasmacytomas, Hodgkin lymphoma, and non-Hodgkin lymphoma metastatic cancer.

Classification

(i) Malignant tumors of the oral cavity

Squamous Cell Carcinoma

Rare malignant tumors

(ii) Pre-cancerous lesions of the oral cavity

(iii) Benign tumors and conditions of the oral cavity

TNM Classification of oral cavity carcinoma

The TNM classification of oral cavity carcinoma is as follows:[1]

TNM Staging for Lip and Oral Cavity Cancers#
Tumor
TX Primary tumor cannot be assessed
T0 Primary tumor cannot be assessed
Tis Carcinoma in situ
T1 Tumor <2 cm or less in greatest dimension
T2 Tumor more than 2 cm but not more than 4 cm in greatest dimension
T3 Tumor more than 4 cm in greatest dimension
T4 (lip) Tumor invades through cortical bone, inferior alveolar nerve, floor of the mouth, or skin of the face (e.g., chin or nose)
T4a (oral cavity) Tumor invades adjacent structures (e.g., through cortical bone into deep [extrinsic] muscle of the tongue [[[genioglossus]], hyoglossus, palatoglossus, and styloglossus], maxillary sinus, or skin of the face)
T4b Tumor invades masticator space, pterygoid plates, or skull base and/or encases internal carotid canal
Regional Lymph Nodes (N)
NX Regional lymph nodes cannot be assessed
N0 No regional lymph node metastasis
N1 Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension
N2a Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension
N2b Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension
N2c Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension
N3 Metastasis in a lymph node more than 6 cm in greatest dimension
Distant Metastasis (M)
MX Distant metastasis cannot be assessed
M0 No distant metastasis
M1 Distant metastasis
M = Distant metastasis; N = regional lymph nodes; T= primary tumor; Tis = carcinoma in situ.

# = Staging system of the American Joint Committee on Cancer.

Staging of Oral Squamous Cell Carcinoma
Stage Description
0 Tis, N0, M0
I T1, N0, M0
II T2, N0, M0
III T3, N0, M0

T1, N1, M0

T2, N1, M0

T3, N1, M0

IVA T4a, N0, M0

T4a, N1, M0

T1, N2, M0

T2, N2, M0

T3, N2, M0

T4a, N2, M0

IVB Any T, N3, M0

T4b, any N, M0

IVC Any T, any N, M1
M = Distant metastasis; N = regional lymph nodes; T = primary tumor; Tis = carcinoma in situ.

References

  1. Sobin, L. H. (2009). TNM classification of malignant tumours. Chichester, West Sussex, UK Hoboken, NJ: Wiley-Blackwell. ISBN 9781444332414.


Template:WH Template:WS

Pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sargun Singh Walia M.B.B.S.[2], Simrat Sarai, M.D. [3]; Grammar Reviewer: Natalie Harpenau, B.S.[4]

Overview

It is understood that oral cancers occur as a the result of carcinogenmetabolizing enzymes, alcohol, tobacco and genetic factors. Cytotoxic enzymes such as alcohol dehydrogenase result in the production of free radicals and hydroxylation of DNA base units. Alcohol dehydrogenase oxidizes ethanol to acetaldehyde which is cytotoxic in nature. Cigarette smoke has various carcinogens, which can lead to oral cancers. Low-reactive free radicals in cigarette smoke interact with redox-active metals in saliva.The development of oral cancer is the result of multiple genetic mutations. These mutations occur in tumor suppressor genes (TSGs) and oncogenes. Squamous cell carcinoma is the most common malignancy of the oral cavity. It typically has three gross morphological growth patterns, which are exophytic, ulcerative, and infiltrative. Microscopically, oral cancers are broadly based and invasive through papillary fronds. Oral cancer consists of highly differentiated squamous cells lacking frank cytologic criteria of malignancy with rare mitoses.The surface of the lesion is covered with compressed invaginating folds of keratin layers. A stroma-like inflammatory reaction and a blunt pushing margin may be seen.

Pathophysiology

It is understood that oral cancer occurs as a the result of carcinogenmetabolizing enzymes, alcohol, tobacco and genetic factors.

Carcinogen-metabolizing enzymes

Alcohol

Tobacco

Pathology of classical or conventional squamous cell carcinoma

Pathology of squamous cell carcinoma variants

  • Verrucous carcinoma
    • These tumors make up less than 5% of all oral cavity tumors.
    • They have a wart-like appearance and develop most often on the gums (gingiva), lining of the cheeks (buccal mucosa) and larynx.
    • Verrucous carcinomas are low grade, slow-growing and rarely spread.
    • They are associated with the chronic use of snuff or chewing tobacco.
  • Basaloid SCC
    • This is a rare but aggressive sub-type of squamous cell carcinoma.
    • It is more common in men older than 60 years old.
  • Papillary SCC
    • This is a rare sub-type of squamous cell carcinoma that grows outward from the surface of the epithelium (exophytic).
    • HPV infections may have a role in the development of this type of cancer.
  • Spindle cell carcinoma (SpCC)
    • This is an aggressive, rare variant of squamous cell carcinoma.
    • These tumors contain a mixture of conventional squamous cell carcinoma and spindle cells that resemble a sarcoma.
    • It is also known as sarcomatoid carcinoma, pseudosarcoma, carcinosarcoma, pleomorphic carcinoma, metaplastic carcinoma, collision tumor and Lane tumor.
  • Acantholytic SCC
  • Adenosquamous carcinoma
    • This is a very rare, aggressive type of squamous cell carcinoma.
    • It looks like classical squamous cell carcinoma but also has mucus-producing gland cells.
  • Lymphoepithelial carcinoma

Genetics

Tumor suppressor genes (TSGs)

Oncogenes

Gross Pathology

  • Squamous cell carcinoma is the most common malignancy of the oral cavity.
  • It typically has three gross morphological growth patterns, which are exophytic, ulcerative, and infiltrative.
  • The infiltrative and ulcerative are the growth patterns most commonly observed in the oral cavity.
  • The macroscopic appearance of oral cancer depends on the following:
    • Duration of the lesion
    • The amount of keratinization
    • The changes in the adjoining mucosa
    • A fully developed oral cavity lesion appears as an exophytic bulky lesion that is gray to grayish-red and has a rough, shaggy, or papillomatous surface
Gross pathology of oral SCC, source: By Luca Pastore, Maria Luisa Fiorella, Raffaele Fiorella, Lorenzo Lo Muzio – http://www.plosmedicine.org/article/showImageLarge.action?uri=info%3Adoi%2F10.1371%2Fjournal.pmed.0050212.g001, CC BY 2.5, https://commons.wikimedia.org/w/index.php?curid=15252632

Microscopic Pathology

  • Microscopically, oral cancers are broadly based and invasive through papillary fronds.
  • Oral cancer constitutes of highly-differentiated squamous cells lacking frank cytologic criteria of malignancy with rare mitoses.
  • The surface of the lesion is covered with compressed invaginating folds of keratin layers.
  • A stroma-like inflammatory reaction and a blunt pushing margin may be seen.
Microscopic picture of oral SCC, source: By No machine-readable author provided. KGH assumed (based on copyright claims). – No machine-readable source provided. Own work assumed (based on copyright claims)., CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=486166

References

  1. Nagler R, Dayan D (2006). “The dual role of saliva in oral carcinogenesis”. Oncology. 71 (1–2): 10–7. doi:10.1159/000100445. PMID 17344667.
  2. Peterson BR, Nelson BL (2013). “Nonkeratinizing undifferentiated nasopharyngeal carcinoma”. Head Neck Pathol. 7 (1): 73–5. doi:10.1007/s12105-012-0401-4. PMC 3597164. PMID 23015393.
  3. Pathmanathan R, Prasad U, Chandrika G, Sadler R, Flynn K, Raab-Traub N (1995). “Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia”. Am J Pathol. 146 (6): 1355–67. PMC 1870892. PMID 7778675.


Template:WH Template:WS

Causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sargun Singh Walia M.B.B.S.[2], Simrat Sarai, M.D. [3]; Grammar Reviewer: Natalie Harpenau, B.S.[4]

Overview

Common causes of oral cancers include premalignant lesions, tobacco, alcohol, human papillomavirus, and hematopoietic stem cell transplantation. Tobacco use is the cause of 75% oral cancer cases . It causes an irritation of mucous membrane in the mouth. HPV type 16 is the most common sub-type of human papilloma virus associated with oral cancer.

Causes

Common causes of oral cancer include:

References

  1. Colvin RB, Pinn VW, Simpson BA, Dvorak HF (1973). “Cutaneous basophil hypersensitivity. IV. The “late reaction”: sequel to Jones-Mote type hypersensitivity. Comparison with rabbit Arthus reaction. Effect of passive antibody on induction and expression of Jones-Mote hypersensitivity”. J. Immunol. 110 (5): 1279–89. PMID 4266835.
  2. Stornetta A, Guidolin V, Balbo S (2018). “Alcohol-Derived Acetaldehyde Exposure in the Oral Cavity”. Cancers (Basel). 10 (1). doi:10.3390/cancers10010020. PMID 29342885.
  3. Shah A, Malik A, Garg A, Mair M, Nair S, Chaturvedi P (2017). “Oral sex and human papilloma virus-related head and neck squamous cell cancer: a review of the literature”. Postgrad Med J. 93 (1105): 704–709. doi:10.1136/postgradmedj-2016-134603. PMID 28778951.


Template:WH Template:WS

Differentiating Oral cancer from other Diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omodamola Aje B.Sc, M.D. [2]; Grammar Reviewer: Natalie Harpenau, B.S.[3]

Overview

There are different types of cancers of the oral cavity and oropharynx. It is important that they are differentiated from one another.

Oral cancer differential diagnosis

The table below outlines the different types of tumors/cancers present in the oral cavity and oropharynx and how they can be differentiated from one another.

Type of cancer Subtype ICD-O Code Epidemiology Etiology Localization Clinical features Diagnostic procedures
Squamous cell carcinoma
  • Basaloid squamous cell carcinoma
  • Papillary squamous cell carcinoma
  • Spindle cell carcinoma
  • Acantholytic squamous cell carcinoma
  • Acantholytic squamous cell carcinoma
  • Adenosquamous carcinoma
Verrucous carcinoma 8051/3
  • Older males
  • 5th and 6th decades of life
  • Males are affected more often than females
  • Hard palate
  • Anterior two-thirds of the tongue, including dorsal, ventral and lateral surfaces, and the floor of mouth
  • Often asymptomatic or may present with vague symptoms and minimal physical finding
Biopsy shows:

Thickened club-shaped

papillae and blunt stromal invaginations

of well-differentiated squamous epithelium with marked keratinization

Lymphoepithelial carcinoma 8082/3 0.8-2% of all oral or oropharyngeal cancers EBV
  • Some tumors can be bilateral
Biopsy chows:
Epithelial precursor lesions Smoking Seen in the entire digestive tract Biopsy shows:
Proliferative verrucous leukoplakia and precancerous conditions
  • Average age at diagnosis is 62 years
  • Women are more commonly affected (ratio, 4:1)
Unknown An aggressive form of oral leukoplakia with considerable morbidity and strong predilection to malignant transformation Biopsy shows:
Papillomas Squamous cell papilloma and

verruca vulgaris

  • Common in children and in adults in the 3rd to 5th decades
  • Almost equal sex incidence with a slight male predominance
HPV sub-types

2, 4, 6, 7,10, and 40

Any oral site may be affected mostly: Soft, pedunculated lesions formed by a cluster of finger-like fronds or a sessile, dome-shaped lesion with a nodular, papillary or verrucous surface Biopsy shows:
Condyloma acuminatum 2nd and 5th decade with a peak in teenagers and young adults
  • HPV– most common sub-types: 6, 11, 16 and 18
  • Painless, rounded, dome-shaped exophytic nodules
  • 15 mm in diameter
  • Have a broad base and a nodular or mulberry-like surface that is slightly red, pink or of normal mucosal color.
  • Lesions may be multiple and are then usually clustered
Biopsy shows:

Several sessile, cauliflower-like swellings forming a cluster

Focal epithelial hyperplasia Disease of children, adolescents and young adults HPV sub types:

13 and 32

  • Soft rounded or flat plaque-like sessile swelling.
  • Usually pink or white in color
  • 2-10 mm in diameter
Biopsy shows:
  • Rounded sessile swelling formed by a sharply demarcated zone of epithelial acanthosis
  • Koilocytes similar to those of squamous papilloma are usually present
Granular cell tumor 9580/0
  • Arise in all age groups, with a peak between 40 and 60 years
  • Females are affected more often than males with an M/F ratio of 2:1
No etiological factors are known
  • The overlying epithelium is of normal color or may be slightly pale
Biopsy shows:
Keratoacanthoma 8071/1
  • Occurs more often in

whites

  • Twice as frequent in

men as in women

Associated with uptake of carcinogens (e.g. via particular smoking habits) Biopsy shows:
Papillary hyperplasia Affects all age groups Associated with: Palate Asymptomatic nodular or papillary mucosal lesion Biopsy shows:
  • Parakeratinisation or less frequently orthokeratinisation
Median rhomboid glossitis Associated with chronic candidal infection Dorsum of the tongue at the junction of the anterior two-thirds

and posterior third

Forms a patch of papillary atrophy in the region of the

embryological foramen caecum

Biopsy shows:
Salivary gland tumors Acinic cell carcinoma 8550/3
  • 2-6.5% of all intra-oral salivary gland tumors
  • Age range from 11-77 years, with a mean of 45 years
  • Male to female ratio of 1.5:1
Unknown Tumors usually

form non-descript swellings

Biopsy shows:
  • Solid sheets of epithelium with secretory material
  • Ductal differentiation in tumors
Mucoepidermoid carcinoma 8430/3
  • 9.5-23% of all minor gland tumors
Unknown Low power microscopy shows low-grade tumor with both cystic and solid areas and an inflamed, fibrous stroma
Adenoid cystic carcinoma 8200/3
  • 42.5% of minor gland tumors
Unknown

Predominantly solid variant shows peri- and intraneural invasion

Epithelial-myoepithelial

carcinoma

8562/3 Unknown
Clear cell carcinoma,

NOS

8310/3 Unknown
Basal cell

adenocarcinoma

8147/3 Rare in minor glands Unknown Asymptomatic, smooth or lobulated sub-mucosal masses Microscopically similar to basal cell adenocarcinomas of the major gland
Cystadenocarcinoma 8450/3 32% developed in the minor glands Unknown Slow growing and painless but somepalatal tumors may erode the underlying bone-causing sinonasal complex
Salivary duct carcinoma 8500/3
  • Rare in minor salivary glands
  • Age range is 23-80 years (mean is 56 years)
Unknown Tumors form painless swellings but many in the palate can be painful and ulcerated or fungated withmetastases to regional lymph nodes The range of

microscopical appearances is similar

to that seen in the major glands

Salivary gland adenomas Pleomorphic adenoma 8940/0 40-70% of minor gland tumors Unknown Painless, slow-growing, submucosal masses, but when traumatized may bleed or ulcerate Biopsy shows cellular, and hyaline or plasmacytoid cell
Myoepithelioma 8982/0 42% of minor gland tumors Unknown
Basal cell adenoma 8147/0 20% of minor gland tumors Unknown They are histologically

similar to those in major glands.

Cystadenoma 8149/0 7% of benign minor gland tumors Uknown
Kaposi sarcoma Biopsy of all 4 types show:
Lymphangioma 9170/0
  • Appear mostly in the head and neck area but may be found in any other part of the body
Tongue
  • Circumscribed painless swelling
  • Soft and fluctuant on palpation
  • Irregular nodularity of the dorsum of the tongue
Biopsy shows:
Ectomesenchymal chondromyxoid

tumour of the anterior tongue

  • Age range varies from 9-78 years
  • No distinct sex predilection.
Unknown Asymptomatic, slow growing solitary nodule in the anterior dorsal tongue Biopsy shows:
Focal oral mucinosis (FOM)
  • The lesion affects all ages
  • Rare in children
  • There is no distinct sex predilection.
Unknown Asymptomatic fibrous or cystic-like lesion Histopathology is characterized by:
  • Mucinous material shows alcianophilia at pH 2.5
Congenital granular cell epuli
  • Affects newborns
  • Females are affected ten times more often than males
Etiology uncertain Solitary, somewhat edunculated fibroma-like lesion, attached to the alveolar ridge near the mid-line
Hematolymphoid tumors Non-Hodgkin lymphoma Second most common cancer of the oral cavity
  • There is no known etiology in most patients
NHL of the lip presents with:

Biopsy shows:

  • Large cells with predominantly round nuclei and membrane-bound nucleoli, consistent with centroblastic morphology.
  • Predominantly medium-sized cells with abundant pale cytoplasm.
  • Large cells with round or multilobated nuclei
Langerhans cell histiocytosis 9751/1 Associated with:
  • Jaw bone
  • Intra-oral soft tissues
  • Gingiva
Common oral symptoms

include:

Biopsy shows ovoid Langerhans cells

with deeply grooved nuclei, thin nuclear membranes and abundant eosinophilic cytoplasm

Hodgkin lymphoma Strongly associated with Epstein- Barr Virus Most patients present with localized disease (stage I/II), with
Extramedullary myeloid

sarcoma

9930/3 History of acute myeloid leukaemia,

predominantly in the monocytic or myelomonocytic sub-types

Isolated tumor-forming intra-oral mass Biopsy shows an Indian-file pattern of infiltration
Follicular dendritic cell

sarcoma / tumour

9758/3
  • Tumor of adulthood
  • Affects wide age range
History of underlying hyaline-vascular Castleman disease The patients usually present with a painless mass Biopsy usually exhibits

borders and comprises:

  • Storiform arrays
  • Diffused sheets of spindle to ovoid tumor cells sprinkled with small lymphocytes
Mucosal malignant melanoma 8720/3
  • 0.5% of oral malignancies
  • Incidence 0.02 per 100,000
No known etiological factors associated with oral melanoma 80% arise:

Others:

  • Floor of mouth
  • Biopsy:
  • S100 positive
  • Negative for cytokeratins
  • More specific markers include:
  • HMB45
  • Melan-A or anti-tyrosinase

References


Template:WH Template:WS

Epidemiology and Demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sargun Singh Walia M.B.B.S.[2], Simrat Sarai, M.D. [3]; Grammar Reviewer: Natalie Harpenau, B.S.[4]

Overview

The prevalence of oral cancer is estimated to be 91,200 cases annually. The incidence of oral cancer is approximately 10.5 adults per 100,000 individuals worldwide with a mortality rate of 1.2 per 100,000 individuals each year. Males are more commonly affected by squamous cell cancer of the oral cavity than females. The male to female ratio is approximately 6 to 1. Females are more commonly affected with adenocarcinoma of the hard palate. Oral cavity cancer usually affects individuals of the black population. Oral cavity cancer usually affects individuals of the lower-income patients.

Epidemiology and Demographics

Prevalence

  • Oral cancer is the 11th most common malignancy, worldwide.[1]
  • In the United States, it is estimated that approximately 91,200 persons are living with oral cancer.
  • It is estimated that about 14% cancers of head and neck are oral cancers (excluding lip cancer).

Incidence

  • The incidence of oral cancer is approximately 8.4 adults per 100,000 individuals worldwide with a mortality rate of 1.2 per 100,000 individuals each year.[2]
  • From 2010 to 2014, the estimated age-adjusted incidence of cancer of the oral cavity and pharynx in the United States was 11.2 cases per 100,000 persons per year.[3] 
  • It is estimated that there will be 49,670 new cases of oral cavity and pharynx cancer diagnosed in the United States in 2017 and 9,700 deaths due to this disease.[4]

Gender

  • Males are more commonly affected by squamous cell cancer of the oral cavity than females.[5]
  • The male to female ratio is approximately 6:1.[5]
  • Females are more commonly affected with adenocarcinoma of the hard palate.

Age

  • The incidence of oral cavity cancer increases with age; the median age at diagnosis is 65 years.

Race

  • Oral cavity cancer usually affects individuals of the black population.
  • Oral cavity cancer usually affects individuals of the lower-income patients.

References

  1. Ghantous Y, Yaffi V, Abu-Elnaaj I (July 2015). “[Oral cavity cancer: epidemiology and early diagnosis]”. Refuat Hapeh Vehashinayim (1993) (in Hebrew). 32 (3): 55–63, 71. PMID 26548152.
  2. Weatherspoon DJ, Chattopadhyay A, Boroumand S, Garcia I (August 2015). “Oral cavity and oropharyngeal cancer incidence trends and disparities in the United States: 2000-2010”. Cancer Epidemiol. 39 (4): 497–504. doi:10.1016/j.canep.2015.04.007. PMC 4532587. PMID 25976107.
  3. “Oral Cavity and Oropharyngeal Cancer Prevention (PDQ®) – National Library of Medicine – PubMed Health”.
  4. “www.cancer.org” (PDF).
  5. 5.0 5.1 “Oral Cancer Incidence (New Cases) by Age, Race, and Gender | National Institute of Dental and Craniofacial Research”.


Template:WH Template:WS

Risk Factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sargun Singh Walia M.B.B.S.[2], Simrat Sarai, M.D. [3]; Grammar Reviewer: Natalie Harpenau, B.S.[4]

Overview

The most potent risk factor in the development of oral cancer is alcohol intake and tobacco use. The other risk factors include male gender, age over 55 years, ultraviolet light, Fanconi anemia, dyskeratosis congenita, HPV infection, graft-versus-host disease (GVHD), mouthwash and irritation from dentures.

Risk Factors

Common risk factors

Less common risk factors

  • Less common risk factors for the development of oral cancer include:
    • According to a study: poor dental hygiene or health and use of dentures made out of metal can lead to increased risk of oral cancer.[9] 
    • Diet
      • Diet low in fruits and vegetables and high in consumption of meats is associated with oral cavity cancer.   
    • Mouthwash[10]
    • Low socioeconomic status

References

  1. Su CC, Yang HF, Huang SJ, Lian I (2007). “Distinctive features of oral cancer in Changhua County: high incidence, buccal mucosa preponderance, and a close relation to betel quid chewing habit”. J. Formos. Med. Assoc. 106 (3): 225–33. PMID 17389167. Vancouver style error: initials (help)
  2. Martín-Hernán F, Sánchez-Hernández JG, Cano J, Campo J, del Romero J (May 2013). “Oral cancer, HPV infection and evidence of sexual transmission”. Med Oral Patol Oral Cir Bucal. 18 (3): e439–44. PMC 3668870. PMID 23524417.
  3. Kim SM (December 2016). “Human papilloma virus in oral cancer”. J Korean Assoc Oral Maxillofac Surg. 42 (6): 327–336. doi:10.5125/jkaoms.2016.42.6.327. PMC 5206237. PMID 28053902.
  4. Sanjaya PR, Gokul S, Gururaj Patil B, Raju R (December 2011). “Candida in oral pre-cancer and oral cancer”. Med. Hypotheses. 77 (6): 1125–8. doi:10.1016/j.mehy.2011.09.018. PMID 21978967.
  5. Muscat JE, Richie JP, Thompson S, Wynder EL (November 1996). “Gender differences in smoking and risk for oral cancer”. Cancer Res. 56 (22): 5192–7. PMID 8912856.
  6. De Benedittis M, Petruzzi M, Giardina C, Lo Muzio L, Favia G, Serpico R (November 2004). “Oral squamous cell carcinoma during long-term treatment with hydroxyurea”. Clin. Exp. Dermatol. 29 (6): 605–7. doi:10.1111/j.1365-2230.2004.01586.x. PMID 15550132.
  7. Ram H, Sarkar J, Kumar H, Konwar R, Bhatt ML, Mohammad S (June 2011). “Oral cancer: risk factors and molecular pathogenesis”. J Maxillofac Oral Surg. 10 (2): 132–7. doi:10.1007/s12663-011-0195-z. PMC 3177522. PMID 22654364.
  8. de Araújo RL, Lyko Kde F, Funke VA, Torres-Pereira CC (2014). “Oral cancer after prolonged immunosuppression for multiorgan chronic graft-versus-host disease”. Rev Bras Hematol Hemoter. 36 (1): 65–8. doi:10.5581/1516-8484.20140016. PMC 3948669. PMID 24624039.
  9. Rosenquist K, Wennerberg J, Schildt EB, Bladström A, Göran Hansson B, Andersson G (2005). “Oral status, oral infections and some lifestyle factors as risk factors for oral and oropharyngeal squamous cell carcinoma. A population-based case-control study in southern Sweden”. Acta Otolaryngol. 125 (12): 1327–36. doi:10.1080/00016480510012273. PMID 16303683.
  10. Scully C (2002). “Oral squamous cell carcinoma; from an hypothesis about a virus, to concern about possible sexual transmission”. Oral Oncol. 38 (3): 227–34. PMID 11978544.


Template:WH Template:WS

Screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sargun Singh Walia M.B.B.S.[2]; Grammar Reviewer: Natalie Harpenau, B.S.[3]

Overview

There is insufficient evidence to recommend routine screening for oral cancer.

Screening

  • There is insufficient evidence to recommend routine screening for oral cancer.[1]
  • There is no country that has any routine screening program for oral cancer.
  • There is insufficient evidence to support any screening modality that might decrease mortality in oral cancer.

References

  1. Speight, Paul M.; Epstein, Joel; Kujan, Omar; Lingen, Mark W.; Nagao, Toru; Ranganathan, Kannan; Vargas, Pablo (2017). “Screening for oral cancer—a perspective from the Global Oral Cancer Forum”. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 123 (6): 680–687. doi:10.1016/j.oooo.2016.08.021. ISSN 2212-4403.


Template:WH Template:WS

Natural History, Complications and Prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sargun Singh Walia M.B.B.S.[2]; Grammar Reviewer: Natalie Harpenau, B.S.[3]

Overview

If left untreated, patients with oral cancer may progress to develop a non-healing ulcer, which demonstrates growth over time. A neck mass may develop, which may cause a mass defect. Depending on the extent of the tumor at the time of diagnosis, the prognosis may vary. The 5-year survival rate for oral cancer that is diagnosed early is 75%, compared to 20% for late diagnosis. Complications of oral cancer include difficulty speaking, dysphagia, weight loss, bleeding and even death.

Natural History

  • Oral cancers usually present late, as they are usually painless and often ignored by the patient.
  • Eventually they present as a non-healing ulcer, which demonstrates growth over time.
  • Due to the extensive lymphatic drainage of the oral cavity, nodal metastases are common at the time of diagnosis.
  • neck mass may be the presenting complaint.
  • Because of the difficulties with direct visualization, they may extend into the tongue or have clinical lymph node metastases before the diagnosis is established.
  • As the tumors enlarge, they may cause a mass effect, which can lead to respiratory compromise when the patient presents late in their illness.[1]

Prognosis

  • 5-year survival rate for oral cancer:
    • Diagnosed early – 75%
    • Diagnosed late – 20%
    • Localized disease at diagnosis – 83%
    • Cancer spread to other parts of the body – 32%
  • Cure rate:
    • 90% – If cancer is found early and before it has spread to other tissues
  • More than 50% oral cancers are diagnosed when they have spread to throat and neck.

Complications

References

  1. Pauloski BR, Rademaker AW, Logemann JA, Colangelo LA (1998). “Speech and swallowing in irradiated and nonirradiated postsurgical oral cancer patients”. Otolaryngol Head Neck Surg. 118 (5): 616–24. doi:10.1177/019459989811800509. PMID 9591859.
  2. Gomez DR, Zhung JE, Gomez J, Chan K, Wu AJ, Wolden SL; et al. (2009). “Intensity-modulated radiotherapy in postoperative treatment of oral cavity cancers”. Int J Radiat Oncol Biol Phys. 73 (4): 1096–103. doi:10.1016/j.ijrobp.2008.05.024. PMID 18707827.
  3. Oh HK, Chambers MS, Martin JW, Lim HJ, Park HJ (2009). “Osteoradionecrosis of the mandible: treatment outcomes and factors influencing the progress of osteoradionecrosis”. J Oral Maxillofac Surg. 67 (7): 1378–86. doi:10.1016/j.joms.2009.02.008. PMID 19531406.


Template:WH Template:WS

Diagnosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | X Ray | CT | MRI | Other Imaging Findings | Other Diagnostic Studies | Staging

Treatment

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case Studies

Case#1

Template:Tumors


Template:WikiDoc Sources

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH